Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,161,252
-
Share change
-
+582,030
-
Total reported value
-
$121,637,838
-
Price per share
-
$8.59
-
Number of holders
-
56
-
Value change
-
+$4,871,369
-
Number of buys
-
38
-
Number of sells
-
16
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q2 2015
As of 30 Jun 2015,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
56 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,161,252 shares.
The largest 10 holders included
ProQuest Associates IV LLC, INVESTOR AB, RA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP LLC, Invesco Ltd., ROYCE & ASSOCIATES LLC, BlackRock Fund Advisors, Cormorant Asset Management, LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, and EAM Investors, LLC.
This page lists
56
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.